Pacific Biosciences Of California (PACB) Change in Account Payables (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Change in Account Payables of -$4.3 million for Q1 2026, down 183.41% year-over-year from $5.2 million in Q1 2025, and down 351.13% quarter-over-quarter from $1.7 million in Q4 2025.
Pacific Biosciences Of California (PACB) Change in Account Payables (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Change in Account Payables history runs 17 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 183.41% year-over-year to -$4.3 million; the TTM figure through Mar 2026 stood at -$315000.0 (up 95.34% YoY), while the FY2025 annual figure was $2.5 million, up 76.65% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$4.3 million, down from $1.7 million in the prior quarter.
- The five-year high for Change in Account Payables was $6.6 million in Q1 2024, with the low at -$5.6 million in Q3 2024.
- The 5-year median for Change in Account Payables is -$486000.0 (2022), against an average of $46823.5.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables surged 4065.36% in 2022, then tumbled 1520.0% in 2023.
- Pacific Biosciences Of California's Change in Account Payables stood at -$486000.0 in 2022, then sank by 208.64% to -$1.5 million in 2023, then soared by 341.8% to $3.6 million in 2024, then tumbled by 52.55% to $1.7 million in 2025, then plunged by 351.13% to -$4.3 million in 2026.
- Business Quant data shows PACB's Change in Account Payables at -$4.3 million in Q1 2026, $1.7 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | 5.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.48 Mn |
| Jun 30, 2026 | 5.48 Mn |
| Mar 31, 2026 | -4.32 Mn |
| Mar 31, 2026 | -4.32 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | -1.53 Mn |
| Mar 31, 2025 | -1.53 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | -5.61 Mn |
| Sep 30, 2024 | -5.61 Mn |
| Jun 30, 2024 | -3.25 Mn |
| Jun 30, 2024 | -3.25 Mn |
| Mar 31, 2024 | 6.64 Mn |
| Mar 31, 2024 | 6.64 Mn |